Cargando…

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma

Research has confirmed that extra spindle pole bodies-like 1 (ESPL1), an etiological factor, promotes the malignant progression of cancers. However, the relationship between ESPL1 and glioma has not yet been demonstrated. The purpose of this study was to reveal the potential mechanisms of ESPL1-medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhendong, Lian, Xiaoyu, Zhang, Xiuru, Zhu, Yongjie, Zhang, Wang, Wang, Jialin, Wang, Hongbo, Liu, Binfeng, Ren, Zhishuai, Zhang, Mengjun, Liu, Mingyang, Gao, Yanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428966/ https://www.ncbi.nlm.nih.gov/pubmed/34512713 http://dx.doi.org/10.3389/fgene.2021.666106

Ejemplares similares

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

Cemented versus uncemented hemiarthroplasty for elderly patients with displaced fracture of the femoral neck: A PRISMA-compliant meta-analysis of randomized controlled trial
por: Liu, Binfeng, et al.
Publicado: (2020)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
por: Song, Rui, et al.
Publicado: (2022)

Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
por: Zhang, Mengjun, et al.
Publicado: (2022)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

Transcriptome Sequencing-Based Mining of Genes Associated With Pubertal Initiation in Dolang Sheep
por: Zhang, Zhishuai, et al.
Publicado: (2022)

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
por: Zhong, Yuchen, et al.
Publicado: (2023)

Exploring the Key Genes and Pathways in the Formation of Corneal Scar Using Bioinformatics Analysis
por: Liu, Binfeng, et al.
Publicado: (2020)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
por: Zhu, Qingyun, et al.
Publicado: (2023)

Genetic Structure and Forensic Feature of 38 X-Chromosome InDels in the Henan Han Chinese Population
por: Zhang, Lin, et al.
Publicado: (2022)

Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma
por: Tao, Bing-Yan, et al.
Publicado: (2022)

Genetic and immune features of resectable malignant brainstem gliomas
por: Zhang, Yang, et al.
Publicado: (2017)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Identification of novel immune ferroptosis-related genes associated with clinical and prognostic features in breast cancer
por: Xie, Zhenlan, et al.
Publicado: (2023)

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma
por: Zhang, Dongdong, et al.
Publicado: (2022)

MMTV-Espl1 Transgenic Mice Develop Aneuploid, Estrogen Receptor Alpha (ERα)-Positive Mammary Adenocarcinomas
por: Mukherjee, Malini, et al.
Publicado: (2013)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

Expression and clinical significance of UBE2V1 in cervical cancer
por: Ren, Zhishuai, et al.
Publicado: (2021)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
por: He, Yi, et al.
Publicado: (2023)

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
por: Liu, Qing, et al.
Publicado: (2023)

Prognostic Roles of Central Carbon Metabolism–Associated Genes in Patients With Low-Grade Glioma
por: Wang, Li, et al.
Publicado: (2019)

The new oncogene transmembrane protein 60 is a potential therapeutic target in glioma
por: Yang, Fengdong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ujqbilap8f0bj9vh3rle8ahr7